On May 18, 2026, MEDLANDER held an investor relations event, with 19 domestic and foreign institutions including Pacific Securities, CITIC Securities, and MingCheng Investment participating in the research. The company's management stated that it has upgraded the strategic core of &#34;women's health and beauty&#34; to &#34;holistic treatment,&#34; relying on brain-computer interface technology to layout high-growth tracks in mental and physical regulation, motor function rehabilitation, and cognitive function intervention, while also promoting the construction of anti-aging centers in public hospitals, expanding new scenarios in urology, and accelerating international layout centered on radar magnetism to open up long-term growth space.
Strategic Upgrade: &#34;Holistic Treatment,&#34; Brain-Computer Interface Layout in Three High-Growth Tracks
The investor relations record shows that MEDLANDER's current strategic upgrade focuses on elevating the treatment model, shifting from traditional physical symptom intervention to dual-system regulation of the central nervous and psychological systems, relying on physical energy technology platforms such as sound, light, electricity, magnetism, and heat, with a focus on three major directions: mental and physical regulation, covering anxiety, depression, insomnia, pelvic floor psychosomatic diseases, urological rehabilitation, and post-operative recovery from tumors; motor function rehabilitation, targeting motor function disorders caused by stroke-related limb movement disorders, spinal cord injuries, and nerve injuries; cognitive function intervention, focusing on early identification and intervention of Alzheimer's disease. The company is simultaneously deepening its strategy from boutique products to explosive products to international products, promoting rapid industrialization of technology.
Brain-Computer Interface Business Becomes Focus of Institutional Attention. The company's non-invasive brain-computer interface devices have been shipped to leading hospitals and are preparing for nationwide multi-center clinical research to promote clinical popularization. This product uses a dual-modal approach of electroencephalography and near-infrared functional imaging, combining technological maturity with spatial resolution, suitable for interventions related to emotions and cognitive issues in the prefrontal cortex. Regarding brain magnetism and brain ultrasound technologies, the company stated that brain magnetism is costly, and the safety verification of brain ultrasound is insufficient, currently only used for research and not yet feasible for large-scale clinical implementation. At this stage, the dual-modal solution can meet the vast majority of clinical treatment needs, and new technologies will be cautiously introduced based on clinical value. The company further stated that non-invasive technology has high patient acceptance and lower promotion difficulty for hospitals, and the current industry is still in its early stages, with the standard system gradually improving. Leading enterprises are more likely to find compliant paths and push to market first, making it easier to seize market opportunities.
Scenario Expansion: Public Anti-Aging Pilot Implementation, Urology Expected to Become a New Growth Point
On the market side, MEDLANDER has partnered with the China Maternal and Child Health Association to initiate the construction of anti-aging centers in public hospitals, using consumer medical operational capabilities to support the public medical system. Consumer medical products have covered four major directions: reproductive beauty, skin beauty, body beauty, and psychological beauty, adhering to integrated diagnosis and treatment, and building a closed-loop health management system for women throughout their life cycle. The company stated that anti-aging centers have already been piloted in multiple hospitals, adopting a self-pay model, establishing an independent pricing and charging system based on relevant pricing guidelines. The operating pressure of public hospitals and the rising demand for consumer medical services provide a favorable environment for rapid business implementation, and once the pilot model is successful, it can be scaled nationwide.
Traditional advantage product radar magnetism is expanding from women's pelvic floor rehabilitation to the field of urology, having been included in relevant expert consensus, launching a new solution with no probe and high comfort, combining serious medical and consumer attributes, which can be implemented in both in-hospital and out-of-hospital health management institutions. The company has formed a special team to tackle the business model, promoting multi-center research and benchmark hospital construction around urology, which is expected to become a new performance growth point
Global Layout: Radar Magnet's Gradual Breakthrough from Southeast Asia to Europe and America
In terms of internationalization, MEDLANDER adopts a regional gradual and core product breakthrough strategy, initially focusing on Southeast Asia, rapidly replicating domestic experience based on population scale, economic stage, and policy compatibility. The radar magnet, with its technological differentiation advantage, will be prioritized as an international product line, and global patent applications have already been initiated. The company's product forms will undergo miniaturization and portability transformation, integrating brain-computer interface technology, and gradually entering mature markets in Europe and America, with subsequent internationalization of other products driven by channel development.
Institutions believe that with the implementation of the mind-body integration strategy, clinical expansion of brain-computer interfaces, expansion of public anti-aging and urology scenarios, and advancement of globalization, MEDLANDER is expected to continuously strengthen its competitiveness in the trend of rehabilitation medical upgrades, achieving dual enhancement of performance and value

688273

MEDLANDER announced at its investor relations event on May 18, 2026, that it will upgrade its "Women's Health and Beauty" strategy to "Holistic Treatment," focusing on the application of brain-machine interface technology in areas such as mental regulation, motor function reconstruction, and cognitive intervention. At the same time, the company plans to promote the construction of anti-aging centers in public hospitals, expand new scenarios in urology and andrology, drive technological commercialization, and enhance market competitiveness

同壁财经

MEDLANDER iterates its "brain-computer interface + mind-body integration" strategy to broaden growth boundaries through multi-business collaboration